Navigation Links
Simcere Pharmaceutical Group Acquires 70% Stake in Wuhu Zhong Ren Pharmaceutical Co. Ltd.
Date:4/21/2008

NANJING, China, April 22 /Xinhua-PRNewswire Simcere Pharmaceutical Group (NYSE: SCR; ''Simcere''), a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endu in China, today announced that it has signed a definitive agreement to acquire a 70% equity interest in Wuhu Zhong Ren Pharmaceutical Co. Ltd. for a total cash consideration of RMB64.82 million (US $9.26 million). This transaction is consistent with Simcere's strategy to focus on first-to-market and innovative new drugs and expand its anti-cancer product portfolio.

Zhong Ren Pharmaceutical is a Chinese drug manufacturer specializing in the production of sustained release anti-tumor implants. Its key product SinoFuan (fluorouracil implant), is proven to effectively inhibit the growth of tumors, and is the only sustained release anti-tumor implant approved by the State Food and Drug Administration (SFDA). SinoFuan is commonly used to treat cancers of the digestive tract and is a favored choice for use during surgery. No similar product exists on the Chinese market today. Distribution of SinoFuan through Simcere's established marketing channels will enhance Simcere's offerings in the anti-cancer drug market, benefit cancer patients across China and create greater value for Simcere shareholders.

About Simcere Pharmaceutical Group

Simcere Pharmaceutical Group (NYSE:SCR; Simcere) is a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endu in the rapidly growing China market. In recent years, Simcere has focused its strategy on the development of first-to-market generic and innovative pharmaceuticals, and has introd
'/>"/>

SOURCE Simcere Pharmaceutical Group
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Simcere Pharmaceutical Group to Announce First Quarter 2008 Earnings on Tuesday, May 6, 2008
2. Simcere Pharmaceutical Group Announces Participation in Brean Murray Carret & Co.s Fourth Investor Tour of China
3. Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2007 Results
4. Simcere Pharmaceutical Group to Announce Fourth Quarter 2007 Earnings on Tuesday, March 4, 2008
5. Simcere Pharmaceutical Group Reports Third Quarter 2007 Results
6. Simcere Pharmaceutical Group Acquires a 51% Stake in Boda Pharmaceutical Co., Ltd.
7. ISTA Pharmaceuticals Announces Conference Call and Webcast of First Quarter 2008 Financial Results
8. Law Offices of Howard G. Smith Announces 21 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Vertex Pharmaceuticals Inc.
9. Amylin Pharmaceuticals Reports First Quarter Financial Results
10. Complementary Excerpt Available from Best Practices: Resources, Structure and Processes to Optimize Pharmaceutical Sales Communications
11. Best Practice Database: Valuable Strategies for Pharmaceutical Product Launches
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... York (PRWEB) April 01, 2015 The ... of Risperdal lawsuits ( http://www.risperdallawsuit2014.com/ ) has scheduled ... calendar for the Philadelphia Court of Common Pleas, the ... 206, City Hall. Court records indicate that the proceeding ... on behalf of Risperdal users who experienced gynecomastia (male ...
(Date:4/1/2015)... Chicago, IL, Northfield, IL, Bethesda, MD, Alexandria, VA ... American Society for Clinical Pathology (ASCP), the College ... Pathology (AMP), and the American Society of Clinical ... clinical practice guideline on the use of molecular ... colorectal carcinoma. This evidence-based guideline will help establish ...
(Date:4/1/2015)... Dr. Daniel C. Stewart ... to discuss the benefits of the LANAP® treatment over ... periodontal disease. People who live in Howard County, and ... can now visit Dr. Stewart, a Maryland dentist, for ... the LANAP® protocol, which is a laser gum surgery ...
(Date:4/1/2015)... 2015 GrassrootsHealth, an international nonprofit ... medical education (CME) courses about vitamin D ... more confident in measuring, prescribing, and tracking vitamin ... these CME courses, practitioners can apply for D*certification ... available are “Vitamin D, Sunshine, Optimal Health: Putting ...
(Date:4/1/2015)... Miramar, FL (PRWEB) April 01, 2015 ... has received Provisional Certificate of Authority (PCOA) approval from ... important step in the ongoing development of a retirement ... enrich individual health, wellness and spiritual development. , America’s ... prepared to meet the housing needs of seniors, according ...
Breaking Medicine News(10 mins):Health News:Pennsylvania Court Overseeing Hundreds of Risperdal Lawsuits Schedules April Meeting 2Health News:Pennsylvania Court Overseeing Hundreds of Risperdal Lawsuits Schedules April Meeting 3Health News:ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period 2Health News:ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period 3Health News:ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period 4Health News:Dr. Daniel C. Stewart Offers Columbia Area Residents an Informational Seminar in April About Less Invasive Gum Disease Treatment Now Available at Smile Savers Dentistry 2Health News:Dr. Daniel C. Stewart Offers Columbia Area Residents an Informational Seminar in April About Less Invasive Gum Disease Treatment Now Available at Smile Savers Dentistry 3Health News:GrassrootsHealth Launches CME Courses about Vitamin D 2Health News:GrassrootsHealth Launches CME Courses about Vitamin D 3Health News:Casa Sant’Angelo Receives Approval for New Retirement Living 2
... Federal Emergency Management Agency (FEMA) of America is under ... stamped on warnings from its own field workers ... housed in government-provided trailers were exposed to levels of ... U.S. workers. ,A trail of e-mails obtained ...
... Thursday banned artificial trans fat and required nutrition labeling for ... applies to Seattle and most of its suburbs despite objections ... produced when hydrogen is added to vegetable oil, increase the ... been linked to obesity, heart disease and diabetes. ...
... People's Congress deputy has called on the Chinese Government ... commercials, at least during the summer and winter holiday ... been convinced about this after hearing her eight-year-old daughter ... don't like fat girls after watching a TV ad ...
... magazine 'Computing Which?' has compiled a list of 101 ... access to advice on almost every matter ranging from ... ,Although the journal has enlisted websites pertaining ... of the most useful and popular sources, such as ...
... lifetime risk of cancer associated with radiation exposure from ... with the risk greater for women and younger patients, ... models. ,The study, published in the journal ... by Andrew J. Einstein, at the Columbia University College ...
... that mature heart cells can not only replicate, but also ... environment. ,The researchers noted that a sponge-like ... the injury can help heart cells to begin dividing and ... component of the material that surrounds cells and is derived ...
Cached Medicine News:Health News:Katrina Evacuees Made To Remain In Toxic Air 2Health News:Artificial Trans Fat Banned in Chain Restaurant in King County 2Health News:101 Websites That can Change Your Life Enlisted 2Health News:Women, Younger Patients at Greater Lifetime Cancer Risk from CT Scan 2Health News:Scientists Demonstrate Heart Cell Replication in Mice 2
(Date:4/1/2015)... Trinity Biotech plc (Nasdaq: TRIB ... products for the point-of-care and clinical laboratory markets, ... wholly-owned subsidiary (the "Issuer"), intends to offer, subject ... principal amount of Exchangeable Senior Notes due 2045 ... pursuant to Rule 144A under the Securities Act ...
(Date:4/1/2015)... 2015  Hologic, Inc. (NASDAQ: HOLX ) announced ... Convertible Exchange Senior Notes due 2037 (CUSIP No. 436440 ... the trustee, paying agent and conversion agent for the ... This conversion right is subject to the terms of ... December 10, 2007, as supplemented by the second supplemental ...
(Date:4/1/2015)... NORTHBROOK, Ill. and ASPEN, Colo. ... Inc., in partnership with the Chris Klug Foundation (CKF), is ... Nominations are now being accepted for the award, which ... post-transplant quality of life, whether it is a career ... leading a fulfilling life with family and loved ones. ...
Breaking Medicine Technology:Trinity Biotech plc Announces Proposed Offering of $100 Million of Exchangeable Senior Notes due 2045 2Trinity Biotech plc Announces Proposed Offering of $100 Million of Exchangeable Senior Notes due 2045 3Trinity Biotech plc Announces Proposed Offering of $100 Million of Exchangeable Senior Notes due 2045 4Hologic Delivers Notice that Holders of 2.00% Convertible Exchange Senior Notes Due 2037 are Eligible to Convert 2Astellas Teams Up with The Chris Klug Foundation on the Bounce Back Award to Recognize Extraordinary Transplant Recipients 2Astellas Teams Up with The Chris Klug Foundation on the Bounce Back Award to Recognize Extraordinary Transplant Recipients 3
... Reportlinker.com announces that a new market research report ... Reportlinker Adds Pharma 101: An Overview of the ... http://www.reportlinker.com/p0155107/Reportlinker-Adds-Pharma-101-An-Overview-of-the-Life-Sciences-Industry-(Analyst-Insight).html , Introduction , The life ... the proper background, it can be difficult for ...
... 16 Reportlinker.com announces that a ... in its catalogue. , ... Market Outlook To 2014: Policy environment, ... , http://www.reportlinker.com/p0155347/Reportlinker-Adds-The-Middle-Eastern-Pharmaceutical-Market-Outlook-To-2014-Policy-environment-market-structure-competitive-landscape-growth-opportunities.html ...
Cached Medicine Technology:Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight) 2Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 2Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 3Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 4Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 5Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 6Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 7Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 8Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 9Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 10Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities 11
... liquid stable reagent offers the laboratory ... stability to help maximize laboratory productivity, ... result turnaround time. The patented technology ... a long shelf life that will ...
... liquid stable reagent offers the laboratory ... stability to help maximize laboratory productivity, ... result turnaround time. The proprietary technology ... a long shelf life that will ...
... Lithium single liquid stable reagent offers ... single liquid stability to help maximize ... provide quick result turnaround time. The ... reagent provides a long shelf life ...
... single liquid stable reagent offers the ... liquid stability to help maximize laboratory ... quick result turnaround time. The proprietary ... reagent provides a long shelf life ...
Medicine Products: